Puma Biotechnology Inc. (PBYI)
NASDAQ: PBYI
· Real-Time Price · USD
5.41
-0.09 (-1.64%)
At close: Oct 16, 2025, 3:59 PM
5.42
0.18%
After-hours: Oct 16, 2025, 06:42 PM EDT
-1.64% (1D)
Bid | 5.24 |
Market Cap | 272.51M |
Revenue (ttm) | 238.06M |
Net Income (ttm) | 48.45M |
EPS (ttm) | 0.99 |
PE Ratio (ttm) | 5.46 |
Forward PE | 16.59 |
Analyst | Buy |
Dividends | n/a |
Ask | 5.75 |
Volume | 450,526 |
Avg. Volume (20D) | 618,279 |
Open | 5.55 |
Previous Close | 5.50 |
Day's Range | 5.33 - 5.75 |
52-Week Range | 2.32 - 6.07 |
Beta | 1.38 |
Ex-Dividend Date | n/a |
About PBYI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PBYI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PBYI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPuma Biotechnology Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+19.73%
Puma Biotechnology shares are trading higher after...
Unlock content with
Pro Subscription

2 months ago · fool.com
Puma (PBYI) Q2 Revenue Rises 11%Puma (PBYI) Q2 Revenue Rises 11%

2 months ago · seekingalpha.com
Puma Biotechnology, Inc. (PBYI) Q2 2025 Earnings Call TranscriptPuma Biotechnology, Inc. (NASDAQ:PBYI ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Alan H. Auerbach - Founder, Chairman, President, CEO & Secretary Heather Blaber ...